NO863620L - Fremgangsmaate for fremstilling av et farmasoeytisk preparat - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Info

Publication number
NO863620L
NO863620L NO863620A NO863620A NO863620L NO 863620 L NO863620 L NO 863620L NO 863620 A NO863620 A NO 863620A NO 863620 A NO863620 A NO 863620A NO 863620 L NO863620 L NO 863620L
Authority
NO
Norway
Prior art keywords
drug
preparing
procedure
pharmaceutical preparation
administration
Prior art date
Application number
NO863620A
Other languages
English (en)
Other versions
NO863620D0 (no
NO171145C (no
NO171145B (no
Inventor
Narendra Raghunathji Desai
Eugene Albert Carpentier
Edward Charles Shinal
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO863620D0 publication Critical patent/NO863620D0/no
Publication of NO863620L publication Critical patent/NO863620L/no
Publication of NO171145B publication Critical patent/NO171145B/no
Publication of NO171145C publication Critical patent/NO171145C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Colloid Chemistry (AREA)
NO863620A 1985-09-11 1986-09-10 Fremgangsmaate for fremstilling av en fettemulsjon med et hydrofobt medikament NO171145C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/774,762 US4816247A (en) 1985-09-11 1985-09-11 Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs

Publications (4)

Publication Number Publication Date
NO863620D0 NO863620D0 (no) 1986-09-10
NO863620L true NO863620L (no) 1987-03-12
NO171145B NO171145B (no) 1992-10-26
NO171145C NO171145C (no) 1993-02-03

Family

ID=25102201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863620A NO171145C (no) 1985-09-11 1986-09-10 Fremgangsmaate for fremstilling av en fettemulsjon med et hydrofobt medikament

Country Status (18)

Country Link
US (1) US4816247A (no)
EP (1) EP0214501B1 (no)
JP (1) JPS62111915A (no)
KR (1) KR900000211B1 (no)
AT (1) ATE80795T1 (no)
AU (1) AU593014B2 (no)
CA (1) CA1272685A (no)
DE (1) DE3686797T2 (no)
DK (1) DK432586A (no)
ES (1) ES2001950A6 (no)
FI (1) FI86142C (no)
GR (1) GR862316B (no)
HU (1) HU196700B (no)
IE (1) IE59828B1 (no)
NO (1) NO171145C (no)
NZ (1) NZ217483A (no)
PH (1) PH24313A (no)
ZA (1) ZA866899B (no)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
US6759057B1 (en) * 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
US5244925A (en) * 1987-12-18 1993-09-14 Kabi Pharmacia Aktiebolag Emulsion for parenteral administration
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
GB2217596A (en) * 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
EP0361928B1 (en) * 1988-09-29 1994-04-27 Shiseido Company Limited Emulsified composition
US4971788A (en) * 1989-01-27 1990-11-20 Medicontrol Corporation Oral cavity and dental microemulsion products
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
US5221535A (en) * 1989-11-13 1993-06-22 Nova Pharmaceutical Corporation Sustained release formulations of insect repellent
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
DE4015108A1 (de) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
GB2260079B (en) * 1991-10-01 1995-08-09 American Cyanamid Co Pharmaceutical composition containing felbinac
JPH06157294A (ja) * 1992-11-19 1994-06-03 Tanabe Seiyaku Co Ltd 脂肪微粒子製剤
DE69328545T2 (de) * 1993-03-24 2001-07-05 Collaborative Laboratories Inc., East Setauket Kosmetisches Verabreichungssystem für Salizylsäure und Verfahren zur Herstellung desselben
US5969004A (en) * 1993-10-15 1999-10-19 The Gillette Company Aqueous inks
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
EP0769936A1 (en) * 1994-07-22 1997-05-02 G.D. Searle & Co. Self-emulsifying drug delivery system
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
UA73715C2 (en) * 1997-09-30 2005-09-15 Lilly Co Eli Pharmaceutically acceptable formulation of olanzapine pamoate and its use for treatment
TWI241915B (en) * 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
AU2001259484A1 (en) 2000-05-05 2001-11-20 Wisconsin Alumni Research Foundation Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
JP2004504342A (ja) * 2000-07-24 2004-02-12 ファルマシア・アンド・アップジョン・カンパニー 極めて水不溶性の脂肪親和性薬剤用の自己乳化性ドラッグデリバリーシステム
BR0214679A (pt) * 2001-12-03 2004-12-14 Novacea Inc Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
EP1506774B1 (en) * 2002-05-22 2011-08-24 Nihon Pharmaceutical Co., Ltd. Smooth muscle peristole inhibitor
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
ES2414084T3 (es) * 2003-02-24 2013-07-18 Pharmaceutical Productions Inc. Sistema de administración de fármacos por vía transmucosa
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US7932249B2 (en) 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
BRPI0801417B8 (pt) * 2008-03-13 2021-05-25 Univ Minas Gerais processo para obtenção de composição farmacêutica de retinóides, produto derivado de retinóides e uso
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
JP5468221B2 (ja) * 2008-08-04 2014-04-09 株式会社 メドレックス 難溶性薬物の静注用分散製剤
MX2011007885A (es) 2009-02-26 2011-12-08 Techno Guard Co Ltd Formulaciones de emulsion de narcoticos para tratamiento de dolor por cancer.
GB201009676D0 (en) * 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
CA2938626A1 (en) * 2013-07-26 2015-01-29 John Rothman Compositions to improve the therapeutic benefit of bisantrene

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172816A (en) * 1963-01-28 1965-03-09 Smith Kline French Lab Method of increasing the oil solubility of compounds and products thereof
US3647624A (en) * 1969-07-24 1972-03-07 Wisconsin Alumni Res Found Treatment of blood with oleaginous substance
JPS5021334B1 (no) * 1970-11-04 1975-07-22
US4124720A (en) * 1970-11-09 1978-11-07 Wenmaekers Georges E J Therapeutic hydrodispersible emulsion
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2313078A1 (fr) * 1975-02-07 1976-12-31 Anvar Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention
US3991206A (en) * 1976-01-15 1976-11-09 American Cyanamid Company Alleviation of eye inflammation by topical application of p-biphenylacetic acid
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
IN150729B (no) * 1978-09-22 1982-11-27 Lever Hindustan Ltd
US4340054A (en) * 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
FR2520253A1 (fr) * 1982-01-28 1983-07-29 Oreal Nouveau systeme emulsionnant a base d'un condensat de proteines, d'un sterol polyoxyethylene et de phosphatide et son utilisation en cosmetique
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
US4563354A (en) * 1983-10-26 1986-01-07 Kabivitrum Ab Oil-in-water emulsion for parenteral administration
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
NZ213008A (en) * 1984-08-22 1989-04-26 Mobil Oil Corp Grease compositions containing diol/boron compound reaction products
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs

Also Published As

Publication number Publication date
KR900000211B1 (ko) 1990-01-23
IE862408L (en) 1987-03-11
HUT43948A (en) 1988-01-28
FI86142C (fi) 1992-07-27
JPS62111915A (ja) 1987-05-22
US4816247A (en) 1989-03-28
ES2001950A6 (es) 1988-07-01
IE59828B1 (en) 1994-04-06
NZ217483A (en) 1990-08-28
DE3686797D1 (de) 1992-10-29
NO863620D0 (no) 1986-09-10
HU196700B (en) 1989-01-30
EP0214501B1 (en) 1992-09-23
ATE80795T1 (de) 1992-10-15
EP0214501A3 (en) 1987-09-09
GR862316B (en) 1987-01-13
CA1272685A (en) 1990-08-14
FI86142B (fi) 1992-04-15
ZA866899B (en) 1987-05-27
AU593014B2 (en) 1990-02-01
NO171145C (no) 1993-02-03
EP0214501A2 (en) 1987-03-18
FI863664A (fi) 1987-03-12
DK432586D0 (da) 1986-09-10
AU6253886A (en) 1987-03-12
FI863664A0 (fi) 1986-09-10
DE3686797T2 (de) 1993-03-25
KR870002834A (ko) 1987-04-13
DK432586A (da) 1987-03-12
NO171145B (no) 1992-10-26
PH24313A (en) 1990-05-29

Similar Documents

Publication Publication Date Title
NO863620L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
MX171191B (es) Composiciones farmaceuticas de glipizida
NO306377B1 (no) Doseform for avgivelse av et medikament
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
DE69627651D1 (de) Formulierungen und zusammensetzungen von in wasser schwer löslichen camptothecinderivaten
NO924209D0 (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
KR910019618A (ko) 발기부전증 치료용 제약 조성물
KR960704543A (ko) 악성 질환의 치료를 위한 비경구투여용 부설판(Parenteral Busulfan for treatment of malignant disease)
KR970025615A (ko) 암 전이 억제제
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
OA07029A (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux.
KR920702225A (ko) 약학 조성물
EP0271151A3 (en) Azumolene dosage form
ES2062763T3 (es) Preparacion farmaceutica de 1-octadecil-2-metil-glicero-3-fosfocolina administrable por via intravenosa.
KR890007728A (ko) 진통제 제조방법
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
AR029415A1 (es) Pirroles sustituidos, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
RU94020614A (ru) Противоопухолевое средство